DKK1 and bone sarcoma: However, our findings have identified autocrine Wnt signaling loop in bone sarcomas, providing a novel target for therapeutic intervention with DKK1 and FRP1 antagonists or other modalities and aiming interfering with cell surface interactions involving Wnts and their receptors.